■Substituted pyrimidone;■Investigational for acute coronary syndrome (phase 3), atherosclerosis (phase 3), and diabetic retinopathy (phase 2);■Lipoprotein-associated phospholipase-A2 (Lp-PLA2) inhibitor. The gene discussed is PLA2G7; the disease is diabetic retinopathy.